Autoantibodies to posttranslationally modified insulin have been detected in patients with T1D, where autoreactivity to oxidized insulin in patients with T1D was more prevalent than native insulin autoantibodies [48•]. This evidence concerns the gene INS and type 1 diabetes mellitus.